Alan H. Auerbach, President and CEO at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 67,682 shares at $3.15 ($213K) on 2025-01-02, disclosed to the SEC on 2025-01-03.
Scheduled sale ($213k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.15 | 33,841 | $107K | 50.0% |
| 2 | $3.15 | 33,841 | $107K | 50.0% |
| Total | $3.15 avg | 67,682 | $213K | 100% |
| Filing → |
| PBYI | SELL | 2025-07-10 | $333K | — | Filing → |
| PBYI | SELL | 2024-07-18 | $81K | — | Filing → |
| PBYI | SELL | 2024-07-02 | $124K | — | Filing → |